Cargando…

Programmed death ligand‐1 regulates angiogenesis and metastasis by participating in the c‐JUN/VEGFR2 signaling axis in ovarian cancer

BACKGROUND: Although programmed cell death‐ligand 1 (PD‐L1) plays a well‐known function in immune checkpoint response by interacting with programmed cell death‐1 (PD‐1), the cell‐intrinsic role of PD‐L1 in tumors is still unclear. Here, we explored the molecular regulatory mechanism of PD‐L1 in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yufei, Xia, Lingfang, Wu, Yong, Zhou, Hongyu, Chen, Xin, Li, Haoran, Xu, Midie, Qi, Zihao, Wang, Ziliang, Sun, Huizhen, Cheng, Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211352/ https://www.ncbi.nlm.nih.gov/pubmed/33939321 http://dx.doi.org/10.1002/cac2.12157

Ejemplares similares

FBP1 regulates proliferation, metastasis, and chemoresistance by participating in C-MYC/STAT3 signaling axis in ovarian cancer
por: Li, Haoran, et al.
Publicado: (2021)

The Fibrillin‐1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells
por: Wang, Ziliang, et al.
Publicado: (2022)

Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2/ITGB6 signaling axis in ovarian cancer
por: Lin, Feikai, et al.
Publicado: (2022)

The regulatory mechanism and biological significance of the Snail-miR590-VEGFR-NRP1 axis in the angiogenesis, growth and metastasis of gastric cancer
por: Mei, Bin, et al.
Publicado: (2020)

PKCθ-JunB axis via upregulation of VEGFR3 expression mediates hypoxia-induced pathological retinal neovascularization
por: Kumar, Raj, et al.
Publicado: (2020)

Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids
por: Li, Qingguo, et al.
Publicado: (2021)

Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells
por: Sun, Huizhen, et al.
Publicado: (2020)

Engineered ligand‐based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesis
por: Kapur, Shiven, et al.
Publicado: (2017)

Jun-APOE-LRP1 axis promotes tumor metastasis in colorectal cancer
por: He, Lingyuan, et al.
Publicado: (2023)

VEGFR1 signaling in retinal angiogenesis and microinflammation
por: Uemura, Akiyoshi, et al.
Publicado: (2021)

Slug regulates the Dll4-Notch-VEGFR2 axis to control endothelial cell activation and angiogenesis
por: Hultgren, Nan W., et al.
Publicado: (2020)

VEGF-dependent tumor angiogenesis requires the inverse and reciprocal regulation of VEGFR1 and VEGFR2
por: Zhang, Zhaocheng, et al.
Publicado: (2009)

VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis
por: D'Haene, Nicky, et al.
Publicado: (2013)

Computational Modeling to Quantify the Contributions of VEGFR1, VEGFR2, and Lateral Inhibition in Sprouting Angiogenesis
por: Kühn, Clemens, et al.
Publicado: (2019)

Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding
por: Gelfand, Maria V, et al.
Publicado: (2014)

The lnc-CTSLP8 upregulates CTSL1 as a competitive endogenous RNA and promotes ovarian cancer metastasis
por: Wang, Xinjing, et al.
Publicado: (2021)

PRMT5 facilitates angiogenesis and EMT via HIF-1α/VEGFR/Akt signaling axis in lung cancer
por: Zheng, Yonghua, et al.
Publicado: (2023)

Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis
por: Stevens, Megan, et al.
Publicado: (2019)

Probiotic Yeast Inhibits VEGFR Signaling and Angiogenesis in Intestinal Inflammation
por: Chen, Xinhua, et al.
Publicado: (2013)

Accelerated Coronary Angiogenesis by Vegfr1-Knockout Endocardial Cells
por: Zhang, Zheng, et al.
Publicado: (2013)

Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway
por: Li, Jia, et al.
Publicado: (2019)

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)

VEGFR-2 conformational switch in response to ligand binding
por: Sarabipour, Sarvenaz, et al.
Publicado: (2016)

The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy
por: Mabeta, Peace, et al.
Publicado: (2022)

SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis
por: Zhou, Huanjiao Jenny, et al.
Publicado: (2018)

Sialyllactose suppresses angiogenesis by inhibiting VEGFR-2 activation, and tumor progression
por: Chung, Tae-Wook, et al.
Publicado: (2017)

TIPE regulates VEGFR2 expression and promotes angiogenesis in colorectal cancer
por: Zhong, Mengya, et al.
Publicado: (2020)

Tetraspanin18 regulates angiogenesis through VEGFR2 and Notch pathways
por: Li, Grace X., et al.
Publicado: (2021)

Small Ribosomal Protein Subunit S7 Suppresses Ovarian Tumorigenesis through Regulation of the PI3K/AKT and MAPK Pathways
por: Wang, Ziliang, et al.
Publicado: (2013)

Short-form RON (sf-RON) enhances glucose metabolism to promote cell proliferation via activating β-catenin/SIX1 signaling pathway in gastric cancer
por: Wang, Ziliang, et al.
Publicado: (2020)

Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells
por: Yang, Yufei, et al.
Publicado: (2018)

Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis
por: Jayasinghe, Caren, et al.
Publicado: (2015)

Extracellular vesicle-derived miR-320a targets ZC3H12B to inhibit tumorigenesis, invasion, and angiogenesis in ovarian cancer
por: Huang, Yan, et al.
Publicado: (2021)

Cinnamon extract inhibits angiogenesis in zebrafish and human endothelial cells by suppressing VEGFR1, VEGFR2, and PKC-mediated MAP kinase
por: Bansode, Rishipal R, et al.
Publicado: (2013)

Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
por: Jiang, Zongru, et al.
Publicado: (2020)

Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts
por: Park, Mi Sun, et al.
Publicado: (2014)

HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells
por: Wang, Lumin, et al.
Publicado: (2018)

The role of the VEGF-C/VEGFR-3 axis in cancer progression
por: Su, J-L, et al.
Publicado: (2007)

The Role of the VEGF-C/VEGFRs Axis in Tumor Progression and Therapy
por: Chen, Jui-Chieh, et al.
Publicado: (2012)

Blockade of VEGFR1 and 2 Suppresses Pathological Angiogenesis and Vascular Leakage in the Eye
por: Huang, Hu, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tn9bi51tfm29njna8np17r9bcj